AS37
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AS37, covering 2026-01-15 to 2026-01-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study on the Safety and Immune Response of AS37 Together With Hepatitis B Antigen in Adults Aged 18-45 Years [Phase 1]